Benjamin  Berry net worth and biography

Benjamin Berry Biography and Net Worth

CFO of Enovis
Ben Berry joined Enovis in 2020 and as of January 2023, succeeds Christopher Hix as the company’s CFO. Mr. Berry has demonstrated strong financial leadership in the medical technology space over his career. Since joining Enovis, he has strengthened the Company’s financial teams and processes, while making significant contributions to Enovis’ improved operating performance and profit margins. He has also played a key role in shaping the Company’s growth strategy, including acquisitions. Previously, Mr. Berry spent 18 years in the medical technologies sector with Alcon, which included its launch as an independent public company. During his tenure, he served in finance leadership roles of increasing responsibility in strategy, operations and business process improvement. He holds an MBA from Kennesaw State University.

What is Benjamin Berry's net worth?

The estimated net worth of Benjamin Berry is at least $937,942.74 as of June 2nd, 2023. Mr. Berry owns 20,223 shares of Enovis stock worth more than $937,943 as of November 17th. This net worth approximation does not reflect any other assets that Mr. Berry may own. Additionally, Mr. Berry receives an annual salary of $1,080,000.00 as CFO at Enovis. Learn More about Benjamin Berry's net worth.

How old is Benjamin Berry?

Mr. Berry is currently 45 years old. There are 7 older executives and no younger executives at Enovis. The oldest executive at Enovis is Ms. Patricia A. Lang, Senior VP & Chief Human Resources Officer, who is 65 years old. Learn More on Benjamin Berry's age.

What is Benjamin Berry's salary?

As the CFO of Enovis Co., Mr. Berry earns $1,080,000.00 per year. There are 3 executives that earn more than Mr. Berry. The highest earning executive at Enovis is Mr. Matthew L. Trerotola, CEO & Chairman, who commands a salary of $3,350,000.00 per year. Learn More on Benjamin Berry's salary.

How do I contact Benjamin Berry?

The corporate mailing address for Mr. Berry and other Enovis executives is 2711 Centerville Road Suite 400, Wilmington DE, 19808. Enovis can also be reached via phone at 302-252-9160 and via email at [email protected]. Learn More on Benjamin Berry's contact information.

Has Benjamin Berry been buying or selling shares of Enovis?

Benjamin Berry has not been actively trading shares of Enovis over the course of the past ninety days. Most recently, Phillip Benjamin (Ben) Berry sold 645 shares of the business's stock in a transaction on Friday, June 2nd. The shares were sold at an average price of $54.17, for a transaction totalling $34,939.65. Following the completion of the sale, the chief financial officer now directly owns 20,223 shares of the company's stock, valued at $1,095,479.91. Learn More on Benjamin Berry's trading history.

Who are Enovis' active insiders?

Enovis' insider roster includes Benjamin Berry (CFO), Christopher Hix (CFO), John Kleckner (Insider), Patricia Lang (SVP), A. Perfall (Director), Daniel Pryor (EVP), Brady Shirley (COO), Bradley Tandy (SVP), Matthew Trerotola (CEO), and Rajiv Vinnakota (Director). Learn More on Enovis' active insiders.

Benjamin Berry Insider Trading History at Enovis

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/2/2023Sell645$54.17$34,939.6520,223View SEC Filing Icon  
3/20/2023Sell600$51.84$31,104.0020,868View SEC Filing Icon  
2/23/2023Sell171$54.62$9,340.0216,630View SEC Filing Icon  
2/21/2023Sell368$62.11$22,856.4816,801View SEC Filing Icon  
See Full Table

Benjamin Berry Buying and Selling Activity at Enovis

This chart shows Phillip Benjamin (Ben) Berry's buying and selling at Enovis by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Enovis Company Overview

Enovis logo
Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.
Read More

Today's Range

Now: $46.38
Low: $45.31
High: $46.61

50 Day Range

MA: $42.44
Low: $38.72
High: $47.86

2 Week Range

Now: $46.38
Low: $38.27
High: $65.03

Volume

467,649 shs

Average Volume

765,955 shs

Market Capitalization

$2.59 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.91